Table 1.
Table 1 (see Figure 4) |
F01d fibroblast activation proteinY10007 |
C09g interleukin 13 receptor alpha (IL-13R- alpha; IL-13RA)S80963 |
E05k maternal embryonic message 2 (MEM2)X95350 |
B14l glycoprotein galactosyltransferase alpha 1, 3M26925 |
B05l crystallin alpha 1J00376 |
A10a zonadhesinU83190 |
A06l cell division cycle 10 homolog (CDC10)AJ223782 |
F10k utrophinX83506 |
C13g low-affinity IgG Fc receptor III (FCGR3)M14215 |
C02e caspase 1 (CASP1); IL-1-beta convertase (IL-1BC); IL-1-beta-converting enzyme (ICE)L28095 |
C01h tumor necrosis factor superfamily member 10 (TNFSF10); TNF-related apoptosis inducing ligand (TRAIL)U37522 |
B13i T-complex protein 1 epsilon subunit (TCP1-epsilon); CCT-epsilon (CCTE; CCT5)Z31555 |
F09m scinderinY13971 |
F01h a disintegrin and metalloproteinase domain 9 (ADAM9); meltrin gammaU41765 |
F13h xeroderma pigmentosum group A complementing protein (XPA)X74351 |
F03j cystatin BU59807 |
E12k phosphatidylinositol 3-kinase, C2 domain containing, alpha polypeptideU52193 |
F06c protein tyrosine phosphatase, receptor type, OU37465 |
E01l interleukin 18 receptor accessory protein (IL-18RAP)AF077347 |
C02c caspase 8 (CASP8)AF067834 |
F07d non-muscle cofilin 1 (CFL1)D00472 |
F11c ataxia telangiectasia mutated in human beings homolog (ATM)U43678 |
E11a cell line NK14 derived transforming oncogeneS53270 |
Note: Formatted to include alphanumeric code gene identifier on Clontech array and brief gene name. For full details see gene list on Clontech web site.